Corbacioglu, S, Cesaro, S, Faraci, M, Valteau-Couanet, D, Gruhn, B, Rovelli, A, Boelens, JJ, Hewitt, A, Schrum, J, Schulz, AS, Muller, I, Stein, J, Wynn, R, Greil, J, Sykora, K, Matthes-Martin, S, Fuhrer, M, O'meara, A, Toporski, J, Sedlacek, P, Schlegel, PG, Ehlert, K, Fasth, A, Winiarski, J, Arvidson, J, Mauz-Korholz, C, Ozsahin, H, Schrauder, A, Bader, P, Massaro, J, D' Agostino, RB, Hoyle, M, lacobelli, M, Debatin, KM, Peters, C & dini, G 2012, '
Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial.',
LANCET ONCOLOGY, vol. 379, no. 9823, pp. 1301-1309.
https://doi.org/10.1016/S0140-6736(11)61938-7